Advances in Antihepato Eellular Carcinoma of Arsenic Trioxide
Abstract:Clinical trials have demonstrated that arsenic trioxide is effective in the treatment of acute promyelocytic leukemia.Based on this fact,more and more studies have been carried out to study its role in the treatment of human hepatocarcinoma cells. Thus we review overseas and domestic literature and summarize treatment of hepatocellular carcinoma with arsenic trioxide for experiments and clinical study.
[18]Takashi Kobayashi,Yasuhiko Sugawara,Ya-Zhou Shi,et a1.Telomerase expression and p53 status in hepatocellular carcinoma[J].Am J Gastroenterol,2002,97(12):3166.
[24]Hong-Yu Xu,You-Lin Yang,Shu-MeiLiu,et a1.Effect of arsenictrioxide on human hepatocarcinoma in nude mice[J]. World J Gastroenterol, 2004,10(24):3677.
[25]Bing Tan,Jie-Fei Huang,QunWei,et a1.Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamid-ofluorene in rats[J].World J Gastroenterol,2005,11(38):5938.